Other cytoskeletal biomarkers: In addition to neurofilaments, other components of the axonal cytoskeleton or other CNS cytoskeletal proteins have been proposed as biomarkers in MS, namely tau protein and glial fibrillary acidic protein (GFAP). The gene discussed is MAPT; the disease is myeloid sarcoma.